Quick Answer
Anixa Biosciences Inc reported Diluted EPS of $0.34 per share (loss) for fiscal year 2025.
Anixa Biosciences Inc Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.34 | +12.8% |
| 2024 | -$0.39 | -21.9% |
| 2023 | -$0.32 | -171.1% |
| 2022 | $0.45 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$0.08 | +20.0% | -14.3% |
| July 31, 2025 | -$0.07 | +30.0% | +22.2% |
| April 30, 2025 | -$0.09 | +10.0% | +10.0% |
| January 31, 2025 | -$0.10 | +0.0% | +0.0% |
| July 31, 2024 | -$0.10 | -25.0% | +0.0% |
| April 30, 2024 | -$0.10 | -42.9% | +0.0% |
| January 31, 2024 | -$0.10 | -225.0% | -25.0% |
| July 31, 2023 | -$0.08 | +11.1% | -14.3% |
- Anixa Biosciences Inc showed an increase of +12.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Anixa Biosciences Inc’s diluted eps has declined by 175.6% (from $0.45 per share to $0.34 per share (loss)).
- The most recent figure is from Anixa Biosciences Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: